Mark Duvall
MarkDuvall
I am a tech and bio tech focused investor who primarily focuses on small cap growth stocks with the potential for multi bagger returns over 12 months or less.
Recent Articles by Mark Duvall
Nov 22, 2013
by Mark Duvall
Could Insiders Selling Organovo Spell Trouble?
Organovo recently soared to the $1 billion level for the first time in its history. But management has been quick to sell stock and file a new equity registration statement. Investors may want to think about selling at these peak prices.
HOW THE MOTLEY FOOL CAN HELP YOU
-
Premium Investing Guidance
Market beating stocks from our award-winning service
-
The Daily Upside Newsletter
Investment news and high-quality insights delivered straight to your inbox
-
Get Started Investing
You can do it. Successful investing in just a few steps
-
Win at Retirement
Secrets and strategies for the post-work life you want.
-
Find a Broker
Find the right brokerage account for you.
-
Listen to our Podcasts
Hear our experts take on stocks, the market, and how to invest.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.